These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8458028)

  • 1. Adenosine and the anti-infarct effects of preconditioning.
    Downey JM; Liu GS; Thornton JD
    Cardiovasc Res; 1993 Jan; 27(1):3-8. PubMed ID: 8458028
    [No Abstract]   [Full Text] [Related]  

  • 2. Infarct size limitation by preconditioning: its phenomenological features and the key role of adenosine.
    Miura T; Iimura O
    Cardiovasc Res; 1993 Jan; 27(1):36-42. PubMed ID: 8458029
    [No Abstract]   [Full Text] [Related]  

  • 3. Ischemic preconditioning and adenosine release.
    Lasley RD
    Circulation; 1993 Sep; 88(3):1354; author reply 1359-60. PubMed ID: 8353897
    [No Abstract]   [Full Text] [Related]  

  • 4. Acadesine lowers temporal threshold for the myocardial infarct size limiting effect of preconditioning.
    Tsuchida A; Liu GS; Mullane K; Downey JM
    Cardiovasc Res; 1993 Jan; 27(1):116-20. PubMed ID: 8458021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular mechanisms in ischemic preconditioning: the role of adenosine and protein kinase C.
    Downey JM; Cohen MV; Ytrehus K; Liu Y
    Ann N Y Acad Sci; 1994 Jun; 723():82-98. PubMed ID: 8030927
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenosine enhanced preservation of myocardial function and energetics. Possible involvement of the adenosine A1 receptor system.
    Mentzer RM; Bünger R; Lasley RD
    Cardiovasc Res; 1993 Jan; 27(1):28-35. PubMed ID: 8458027
    [No Abstract]   [Full Text] [Related]  

  • 7. Ischaemic preconditioning: can the protection be bottled?
    Cohen MV; Downey JM
    Lancet; 1993 Jul; 342(8862):6. PubMed ID: 8100337
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart.
    Liu GS; Richards SC; Olsson RA; Mullane K; Walsh RS; Downey JM
    Cardiovasc Res; 1994 Jul; 28(7):1057-61. PubMed ID: 7954592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An adenosine A1 receptor agonist, R(-)-N-(2-phenylisopropyl)-adenosine (PIA), but not adenosine itself, acts as a therapeutic preconditioning-mimetic agent in rabbits.
    Hale SL; Bellows SD; Hammerman H; Kloner RA
    Cardiovasc Res; 1993 Dec; 27(12):2140-5. PubMed ID: 8313421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size.
    Lasley RD; Konyn PJ; Hegge JO; Mentzer RM
    Am J Physiol; 1995 Oct; 269(4 Pt 2):H1460-6. PubMed ID: 7485581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with the adenosine A1 selective agonist, 2-chloro-N6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in rabbits.
    Tsuchida A; Liu GS; Wilborn WH; Downey JM
    Cardiovasc Res; 1993 Apr; 27(4):652-6. PubMed ID: 8324800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitation of infarct size by myocardial ischemic preconditioning.
    Van Winkle DM
    Basic Res Cardiol; 1996; 91(1):38-40. PubMed ID: 8660255
    [No Abstract]   [Full Text] [Related]  

  • 13. The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart.
    Tsuchida A; Thompson R; Olsson RA; Downey JM
    J Mol Cell Cardiol; 1994 Mar; 26(3):303-11. PubMed ID: 8028014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acadesine extends the window of protection afforded by ischaemic preconditioning.
    Tsuchida A; Yang XM; Burckhartt B; Mullane KM; Cohen MV; Downey JM
    Cardiovasc Res; 1994 Mar; 28(3):379-83. PubMed ID: 8174159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs.
    Auchampach JA; Gross GJ
    Am J Physiol; 1993 May; 264(5 Pt 2):H1327-36. PubMed ID: 8498546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits.
    Burckhartt B; Yang XM; Tsuchida A; Mullane KM; Downey JM; Cohen MV
    Cardiovasc Res; 1995 May; 29(5):653-7. PubMed ID: 7606753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An increase in adenosine release contributes to the infarct size limiting effect of ischemic preconditioning].
    Hori M; Kitakaze M; Morioka T; Minamino T; Takashima S; Sato H; Node K; Shinozaki Y; Chujo M; Mori H
    Jpn Circ J; 1993; 57 Suppl 4():1330-2. PubMed ID: 7966979
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning.
    Tsuchida A; Miura T; Miki T; Shimamoto K; Iimura O
    Cardiovasc Res; 1992 May; 26(5):456-61. PubMed ID: 1446315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts.
    Hoshida S; Kuzuya T; Nishida M; Yamashita N; Oe H; Hori M; Kamada T; Tada M
    Cardiovasc Res; 1994 Jul; 28(7):1083-8. PubMed ID: 7954595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KATP channels in ischaemic preconditioning.
    Parratt JR; Kane KA
    Cardiovasc Res; 1994 Jun; 28(6):783-7. PubMed ID: 7923280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.